Imaging more frequently drives decision to increase treatment in pleural infection than clinical condition

C. Wilshire (Seattle, United States of America)

Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Session: Pleural disease and mesothelioma: from the bench to the bedside
Session type: Oral Presentation
Number: 295
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Wilshire (Seattle, United States of America). Imaging more frequently drives decision to increase treatment in pleural infection than clinical condition. 295

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How much of a role does immunohistochemistry have in reaching a final diagnosis of pleural malignancy in routine clinical practice?
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


How often is a single therapeutic aspiration sufficient to manage a malignant pleural effusion and does oncological treatment have an impact on this?
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019

T-cell interferon-γ release assay for the diagnosis of tuberculous pleuritis in routine clinical practice
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007



How can radiology assist in the diagnosis and management of pleural infection
Source: International Congress 2018 – Management of pleural infection in 2018
Year: 2018


Clinical management: recommended practice including the place of antibiotics
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007



The minimal important difference for target lobe volume reduction following endoscopic valve therapy in patients with advanced emphysema
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


Time related change of etiologi and outcome in two large cohorts of pleural infection.
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017

Surgical management of pleural infection - who to operate on and when
Source: International Congress 2018 – Management of pleural infection in 2018
Year: 2018


Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 669s
Year: 2006

Digital airflow measurement early in treatment course for spontaneous pneumothorax predicting surgical referral
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018



Outcome after interventionel lungvolume reduction with coils (LVRC) dependent from the initial clinical presentation
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016

Understanding how variation in clinical practice affects length of stay for patients with malignant pleural effusion.
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019

Does large airway intervention for patients with malignant disease result in early clinical benefit?
Source: Annual Congress 2008 - Hot and cold techniques
Year: 2008


Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009

Variable radiological lung nodule evaluation leads to divergent management recommendations
Source: Eur Respir J, 52 (6) 1801359; 10.1183/13993003.01359-2018
Year: 2018



Do results of T-SPOT.TB assays change during and after treatment of active tuberculosis?
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006


Does timeliness of diagnosis influence survival and treatment response in idiopathic pulmonary fibrosis?  Real- world results from the EMPIRE registry.
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017

Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009


RECEIVER trial: positive early experience and sustained patient engagement with a digital service model for COPD management
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020


Optimal diagnosis and treatment of malignant pleural disease: challenging the guidelines
Source: Eur Respir Monogr 2020; 87: 138-154
Year: 2020